INTRALIPID
Generic: I.V. FAT EMULSION
Fresenius Kabi USAManufacturer
INTRAVENOUSRoute
SOYBEAN OILActive Substance
1981-01-23Original Approval
INTRALIPID is FDA application NDA018449, sponsored by FRESENIUS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2022-04-13
Intralipid (I.V. Fat emulsion), 20%, 250 mL bag, Rx only, MFG: Baxter Healthcare, NDC 0338-0519-09cGMP deviations: Temperature abuse
Class I2017-09-15
Intralipid 20%, A 20% I.V. Fat Emulsion, 100 ml bag, Rx only, Manufactured by Fresenius Kabi, Uppsala, Sweden for BaxterTemperature Abuse: A portion of this product lot was exposed to subfreezing temperatures, which is o
Class II2022-04-13
Intralipid (I.V. Fat emulsion), 20%, 100 mL bag, Rx only, MFG: Baxter Healthcare, NDC 0338-0519-58cGMP deviations: Temperature abuse
Top Reported Reactions
1
CHILLS
75 reports
2
PYREXIA
57 reports
3
PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE
56 reports
4
NAUSEA
53 reports
5
DYSPNOEA
46 reports
6
VOMITING
45 reports
7
CHEST DISCOMFORT
42 reports
8
DIARRHOEA
36 reports
9
OFF LABEL USE
35 reports
10
WEIGHT DECREASED
35 reports